查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087622

移植市場：2026-2032年全球市場預測（依器官類型、產品類型、捐贈者類型、手術類型和最終用戶分類）

Transplantation Market by Organ Type, Product Type, Donor Type, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，器官移植市場將成長至 219.9 億美元，複合年成長率為 9.20%。

主要市場統計數據
基準年 2025 118.7億美元
預計年份：2026年 128.4億美元
預測年份 2032 219.9億美元
複合年成長率 (%) 9.20%

器官移植，包括腎臟、肝臟、心臟、肺臟、胰臟、腸道、組織、角膜、造血幹細胞，甚至包括新型細胞療法，已成為現代醫學的重要支柱。然而，需求持續超過供應。世界衛生組織全球器官捐贈和移植觀察站報告稱，全球每年進行的固態器官移植手術超過15萬例，但這僅佔估計臨床需求的一小部分。

造血幹細胞移植治療慢性腎臟病、糖尿病、肝功能衰竭、心肺疾病和癌症的數量不斷增加，以及末期器官疾病患者生存期的延長，共同推動了這個市場的發展。此外，免疫抑制療法、器官保存技術、捐贈者配對、移植診斷技術的進步，以及國家登記系統的擴展（提高了透明度、可追溯性和分配效率），也促進了市場成長。

移植醫學領域的變革性變化

器官移植的治療方法正從純粹的外科手術轉向整合供體識別、器官獲取、灌注、診斷、物流、手術、免疫學以及終身移植後監測的「移植生態系統」。機械灌注、常溫儲存、先進的低溫運輸物流以及組織相容性檢測技術的進步，正在擴大可用於移植的高風險器官的範圍，為改善器官移植的可及性創造了新的機會。

人工智慧對移植領域的累積影響

人工智慧（AI）正整體成為移植醫學領域的一股強大驅動力，尤其是在捐贈者配對、器官活力評估、等待名單優先排序、移植後風險預測、觀察理解、影像分析和遠端患者監護等方面。透過在檢驗的臨床資料集上訓練AI模型，並將其與實際治療結果進行對比，可以幫助識別排斥反應、感染疾病、移植失敗或藥物依從性等早期徵兆。

移植市場的關鍵區域洞察

北美仍然是器官移植領域最先進的地區之一，這得益於成熟的器官捐贈組織、覆蓋全國的器官分配系統、積極的臨床試驗活動以及健全的保險報銷體系。在美國，全國器官捐贈和移植數據顯示，移植率屢創新高；而在加拿大，省際合作、提高腦死捐贈器官的利用率、發展活體捐贈項目以及確保地域分散的人口都能公平地獲得器官，仍然是重點工作。

針對特定群體的策略性移植評估的關鍵見解

七國集團（G7）國家擁有高額的醫療費用支出、完善的大學附屬醫院、先進的登記系統，以及廣泛的複雜外科手術、免疫學、診斷和移植後追蹤服務，因此具備重要的器官移植能力。北約成員國也擁有高度集中的器官移植基礎設施，器官捐贈、物流、國家分配法規和臨床管治體系相對成熟，尤其是在北美和歐洲。

主要國家在移植方面的見解

美國在器官移植數量、創新和臨床研究方面均處於世界領先地位，並積極參與腎臟、肝臟、心臟、肺臟、胰臟、腸道、組織和造血幹細胞移植。加拿大強調公平獲取器官、省際合作以及對活體捐贈者的支持，而墨西哥儘管面臨腦死捐獻率居高不下和區域間器官獲取差異等問題，仍在不斷擴大其移植能力。巴西擁有拉丁美洲最大的器官移植系統，該系統由公共器官獲取、專業中心和全國協調網路提供支持，並在該地區的腎臟、肝臟、心臟和角膜移植活動中繼續發揮核心作用。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠增加可用器官供應、縮短缺血時間並改善移植器官長期預後的解決方案。投資於機械灌注、數位化捐贈者管理、組織學相容性檢測、分子診斷、藥物監測、非侵入性排斥反應監測以及移植後遠端監測，可以解決臨床和營運方面的瓶頸問題。

調查方法

本執行摘要基於二手研究，使用了公開的移植登記資料、衛生當局出版刊物、同行評審的臨床文獻、醫院網路資料、政策文件和監管資訊來源。主要資訊來源通常包括世界衛生組織全球器官捐贈和移植觀察站、國家移植登記資料、器官取得和移植資料系統、歐洲移植網路、國家血液和移植管理機構以及區域衛生署。

結論

移植醫學正邁向一個更數據主導和技術驅動的階段，器官供應、移植品質、物流精準性、臨床管治和長期病患管理已成為影響市場成功的關鍵因素。由於慢性病高發生率、人口老化、末期器官衰竭病例增加以及移植等待者和可用捐贈者之間持續存在的缺口，移植需求依然居高不下。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 移植市場：依器官類型分類

  • 心
  • 腸子
  • 腎
  • 肝
  • 肺
  • 胰臟

第8章：移植市場：依產品類型分類

  • 消耗品
    • 導管
    • 接枝
    • 縫合線
  • 醫療設備
    • 監控設備
    • 灌注裝置
    • 防腐液
  • 植入
    • 人工器官
    • 血管移植
  • 製藥
    • 抗增殖劑
    • Calcineurin抑制劑
    • 皮質類固醇
    • mTOR抑制劑

第9章 移植市場：依供體類型分類

  • 已故捐贈者
  • 活體捐贈者

第10章 移植市場：依手術類型分類

  • 腹腔鏡
  • 打開
  • 機器人支援

第11章：移植市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 移植市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 移植市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 移植市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 21st Century Medicine
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Baxter International Inc.
  • Bio-Rad Laboratories, Inc.
  • BiolifeSolutions, Inc.
  • Bristol-Myers Squibb Company
  • CHIESI Farmaceutici SpA
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Organ Recovery Systems, Inc.
  • Organovo, Inc.
  • OrganOx Limited
  • Pfizer Inc.
  • Plexision, Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-031685195793

The Transplantation Market is projected to grow by USD 21.99 billion at a CAGR of 9.20% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.87 billion
Estimated Year [2026] USD 12.84 billion
Forecast Year [2032] USD 21.99 billion
CAGR (%) 9.20%

Transplantation is a critical pillar of modern healthcare, spanning kidney, liver, heart, lung, pancreas, intestine, tissue, corneal, hematopoietic stem cell, and emerging cell-based procedures. Demand continues to outpace supply: the WHO Global Observatory on Donation and Transplantation has reported more than 150,000 solid organ transplants annually worldwide, yet this represents only a fraction of estimated clinical need.

The market is shaped by rising chronic kidney disease, diabetes, liver failure, cardiopulmonary disease, cancer-related stem cell transplantation, and longer survival among patients with end-stage organ disease. Growth is also supported by improved immunosuppression, organ preservation technologies, donor-recipient matching, transplant diagnostics, and expanding national registries that improve transparency, traceability, and allocation efficiency.

Transformative Shifts in the Transplantation Landscape

The transplantation landscape is shifting from procedure-led care toward integrated transplant ecosystems that combine donor identification, organ recovery, perfusion, diagnostics, logistics, surgery, immunology, and lifelong post-transplant monitoring. Machine perfusion, normothermic preservation, advanced cold-chain logistics, and improved histocompatibility testing are extending the usability of higher-risk organs and creating new opportunities to improve transplant access.

At the same time, health systems are placing greater emphasis on equity, living donation safety, deceased donor optimization, and value-based outcomes. The industry is moving beyond survival as the only benchmark and increasingly measuring graft longevity, quality of life, readmission rates, rejection episodes, infection control, medication adherence, and long-term immunosuppression management.

Cumulative Impact of Artificial Intelligence in Transplantation

Artificial intelligence is becoming a high-impact enabler across transplantation, particularly in donor-recipient matching, organ viability assessment, waitlist prioritization, post-transplant risk prediction, pathology interpretation, imaging analysis, and remote patient monitoring. AI models can help identify early signs of rejection, infection, graft dysfunction, or medication non-adherence when trained on validated clinical datasets and monitored against real-world outcomes.

The cumulative impact is not limited to clinical decisions. AI-supported logistics can improve organ transport routing, reduce cold ischemia time, and support operating room coordination, while predictive analytics can strengthen donor referral workflows and post-discharge care. However, responsible adoption requires explainable algorithms, bias testing, clinical validation, cybersecurity safeguards, human oversight, and compliance with medical device and data protection regulations.

Key Regional Insights Across Transplantation Markets

North America remains one of the most advanced transplantation regions, supported by mature organ procurement organizations, national allocation systems, high clinical trial activity, and strong reimbursement infrastructure. The United States has repeatedly reported record transplant activity through national procurement and transplantation data, while Canada continues to emphasize interprovincial coordination, deceased donation improvement, living donation programs, and equitable access across geographically dispersed populations.

Europe benefits from well-established transplant networks, quality registries, cross-border collaboration, and strong leadership from countries such as Spain, the United Kingdom, Germany, France, and Italy. European programs are supported by structured donor safety rules, tissue and cell quality standards, and long-running national registries that help benchmark clinical outcomes. Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia strengthen transplant capacity, living donor programs, transplant governance, and regulatory oversight, with demand reinforced by diabetes, kidney disease, liver disease, and aging populations.

Latin America shows steady progress led by Brazil and Mexico, though access remains constrained by uneven hospital infrastructure, donor identification capacity, intensive care availability, and regional disparities. The Middle East is investing in specialist transplant centers, national donation frameworks, and self-sufficiency initiatives to reduce dependence on outbound care. Africa presents long-term potential as dialysis demand, workforce development, transplant training, tissue typing capacity, ethical donation systems, and public awareness programs expand, although many countries continue to face limitations in financing, critical care infrastructure, and post-transplant medicine access.

Key Group Insights for Strategic Transplantation Assessment

The G7 accounts for a large base of advanced transplantation capacity due to high healthcare spending, established academic medical centers, sophisticated registries, and broad availability of complex surgery, immunology, diagnostics, and post-transplant follow-up. NATO countries also represent a significant concentration of transplant infrastructure, particularly in North America and Europe, where procurement, logistics, national allocation rules, and clinical governance are comparatively mature.

The European Union supports transplantation through regulatory harmonization, safety standards, vigilance systems, traceability requirements, and cross-border collaboration for organs, tissues, and cells. BRICS nations are increasingly important because of population scale, expanding healthcare investment, rising chronic disease burden, and ongoing efforts to formalize donation systems and transplant regulation. ASEAN markets are at different stages of transplant system maturity, with Singapore, Thailand, and Malaysia advancing specialized services, while broader regional development depends on donor awareness, workforce training, and financing capacity. GCC countries are investing in transplant centers, deceased donation frameworks, and national registries to reduce outbound medical travel, improve self-sufficiency, and strengthen continuity of care for kidney, liver, and other complex transplant procedures.

Key Country Insights in Transplantation

The United States leads in transplant volume, innovation, and clinical research, with strong activity in kidney, liver, heart, lung, pancreas, intestine, tissue, and hematopoietic stem cell transplantation. Canada emphasizes equitable access, interprovincial coordination, and living donation support, while Mexico is expanding transplant capacity amid persistent gaps in deceased donation rates and regional access. Brazil is Latin America's largest transplantation system, supported by public-sector procurement, specialized centers, and national coordination, and it remains central to regional kidney, liver, heart, and corneal transplant activity.

In Europe, the United Kingdom, Germany, France, Italy, and Spain anchor advanced transplant services through national registries, specialized surgical centers, donor coordination, and long-term outcome monitoring. Spain is widely recognized for deceased donation performance and intensive care-based donor identification, while Germany and France maintain deep clinical expertise in complex organ and tissue transplantation. The United Kingdom has strong national coordination and blood, organ, tissue, and stem cell infrastructure; Italy combines national oversight with strong regional transplant networks; Spain continues to set benchmarks in donation organization; and Russia maintains transplant capacity across major urban centers, with activity concentrated in specialized hospitals.

In Asia-Pacific, China has expanded transplant governance, hospital capability, and regulatory oversight, while India is growing rapidly in kidney and liver transplantation through both public and private sector capacity. Japan remains highly specialized with a distinctive deceased donation environment and strong expertise in living donor and advanced surgical procedures. Australia maintains strong clinical quality, national coordination, and transparent reporting, and South Korea is a regional leader in advanced surgical techniques, immunology, living donor transplantation, and high-complexity hospital infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize solutions that increase usable organ supply, shorten ischemia time, and improve long-term graft outcomes. Investments in machine perfusion, digital donor management, histocompatibility testing, molecular diagnostics, therapeutic drug monitoring, noninvasive rejection surveillance, and post-transplant remote monitoring can address both clinical and operational bottlenecks.

Strategic partnerships with transplant centers, organ procurement organizations, blood and marrow registries, diagnostics providers, logistics specialists, and public health agencies will be essential. Leaders should also build evidence packages demonstrating survival benefits, graft longevity, reduced rejection, cost-effectiveness, workflow efficiency, and lower hospital utilization to support payer adoption, clinical confidence, and regulatory review.

Research Methodology

This executive summary is based on secondary research from publicly available transplantation registries, health authority publications, peer-reviewed clinical literature, hospital network data, policy documents, and regulatory sources. Key sources typically include the WHO Global Observatory on Donation and Transplantation, national transplant registries, organ procurement and transplantation data systems, European transplant networks, national blood and transplant authorities, and regional health ministries.

The methodology triangulates procedure activity, disease burden indicators, reimbursement patterns, regulatory developments, technology adoption, donor availability, waiting list dynamics, and clinical outcomes. Insights are validated through consistency checks across multiple sources and organized to reflect market dynamics, regional variation, artificial intelligence impact, technology adoption, ethical considerations, and strategic implications for stakeholders.

Conclusion

Transplantation is entering a more data-driven, technology-enabled phase in which organ availability, graft quality, logistics precision, clinical governance, and longitudinal patient management determine market success. Demand remains structurally high because of chronic disease prevalence, aging populations, rising end-stage organ failure, and the persistent gap between patients awaiting transplantation and available donors.

Organizations that combine clinical credibility, regulatory discipline, ethical governance, equitable access strategies, and digital innovation will be best positioned to improve outcomes and support sustainable growth. The next phase of competition will be defined by measurable impact on transplant access, graft survival, operational efficiency, donor utilization, patient safety, and quality of life.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transplantation Market, by Organ Type

  • 7.1. Heart
  • 7.2. Intestine
  • 7.3. Kidney
  • 7.4. Liver
  • 7.5. Lung
  • 7.6. Pancreas

8. Transplantation Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Catheters
    • 8.1.2. Grafts
    • 8.1.3. Sutures
  • 8.2. Devices
    • 8.2.1. Monitoring Devices
    • 8.2.2. Perfusion Devices
    • 8.2.3. Preservation Solutions
  • 8.3. Implants
    • 8.3.1. Artificial Organs
    • 8.3.2. Vascular Grafts
  • 8.4. Pharmaceuticals
    • 8.4.1. Antiproliferative Agents
    • 8.4.2. Calcineurin Inhibitors
    • 8.4.3. Corticosteroids
    • 8.4.4. Mtor Inhibitors

9. Transplantation Market, by Donor Type

  • 9.1. Deceased Donor
  • 9.2. Living Donor

10. Transplantation Market, by Procedure Type

  • 10.1. Laparoscopic
  • 10.2. Open
  • 10.3. Robotic

11. Transplantation Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Transplantation Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Transplantation Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Transplantation Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 21st Century Medicine
  • 16.2. AbbVie Inc.
  • 16.3. Astellas Pharma Inc.
  • 16.4. Baxter International Inc.
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. BiolifeSolutions, Inc.
  • 16.7. Bristol-Myers Squibb Company
  • 16.8. CHIESI Farmaceutici S.p.A.
  • 16.9. Dr. Franz Kohler Chemie GmbH
  • 16.10. F. Hoffmann-La Roche AG
  • 16.11. Illumina, Inc.
  • 16.12. Johnson & Johnson
  • 16.13. Medtronic PLC
  • 16.14. Merck KGaA
  • 16.15. Novartis AG
  • 16.16. Organ Recovery Systems, Inc.
  • 16.17. Organovo, Inc.
  • 16.18. OrganOx Limited
  • 16.19. Pfizer Inc.
  • 16.20. Plexision, Inc.
  • 16.21. Sanofi S.A.
  • 16.22. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSPLANTATION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSPLANTATION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSPLANTATION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSPLANTATION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTESTINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTESTINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTESTINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LUNG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LUNG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LUNG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SUTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERFUSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERFUSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PRESERVATION SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PRESERVATION SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANTIPROLIFERATIVE AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTIPROLIFERATIVE AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANTIPROLIFERATIVE AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CALCINEURIN INHIBITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CALCINEURIN INHIBITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CALCINEURIN INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MTOR INHIBITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MTOR INHIBITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MTOR INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DECEASED DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DECEASED DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DECEASED DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIVING DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIVING DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LIVING DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LAPAROSCOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LAPAROSCOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LAPAROSCOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL OPEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OPEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OPEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ROBOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ROBOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ROBOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. GCC TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 173. GCC TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 176. GCC TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. G7 TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 203. G7 TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. G7 TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 206. G7 TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 213. NATO TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NATO TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 216. NATO TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. ITALY TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. ITALY TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 317. SPAIN TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. SPAIN TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. SPAIN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. INDIA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. INDIA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. INDIA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 337. INDIA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. INDIA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. INDIA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. JAPAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. JAPAN TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 347. JAPAN TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. JAPAN TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. JAPAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. AUSTRALIA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 354. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 355. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 356. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 357. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 359. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. SOUTH KOREA TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 362. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 364. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 365. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 366. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 367. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 369. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)